BNET Industries
Pfizer Inc. (PFE) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $48.4B
- Profit
- Dec 31 2007
- $8.1B
- Market Cap
- Nov 20 2008
- $97.4B
Latest News and Analysis
A Ranbaxy Bid Would Smell Like Desperation on Pfizer
Last last week, reports out of India suggested that Pfizer might make a hostile bid for generic-drug maker Ranbaxy Laboratories, which last week agreed to sell itself to Japan's Daiichi Sankyo for roughly $4 billion. Pfizer may or may not actually try to bust up the Daiichi-Ranbaxy...
Local insurer takes on Pfizer; Drug was illegally pushed, suit says.
Byline: Andrew Dietderich Dearborn-based Midwest Health Plan Inc. filed a class-action suit Monday against New York City-based Pfizer Inc. alleging illegal marketing practices caused doctors to overprescribe the drug Neurontin, unnecessarily costi Byline: Andrew Dietderich Dearborn-based Midwest Health Plan Inc....
Pfizer settles fraud case for $430M
NEW YORK -- Pharmaceutical giant Pfizer agreed to pay $430 million and plead guilty to charges that its epilepsy drug, Neurontin, was marketed for uses unapproved by the federal government. The penalties include a $240 million criminal fine, the second-largest criminal fine in a health care fraud prosecution, the...
Evolution of breath strips: the category, worth about half of the global mouth fresheners sector, has proved explosively popular
The breath strip--also known as mouth freshening strip--category was created by Pfizer's Warner-Lambert consumer healthcare division in August 2000 with the development of Listerine PocketPaks Breath Freshening Strips, although they did not hit supe The breath strip--also known as mouth freshening strip--category was created by...
Pfizer's solid growth prospects: consumer products united under Warner-Lambert name
Pfizer Inc. (NYSE: PFE; Recent price: US$41), which in 2000 merged with its rival Warner-Lambert, is now one of the top drug makers in the world. It is also the fastest growing large capitalization drug company. Pfizer's products include such prescription drugs as impotence treatment Viagra, cardiovascular drug Norvasc, and...
Omnicom agency makes Pfizer bid a three-way race; Creative Media joins MindShare, Carat in review.(Brief Article)(Statistical Data Included)(Illustration)
A dark horse has emerged in the review to consolidate the estimated $738 million Pfizer and Warner-Lambert media buying and planning accounts. A dark horse has emerged in the review to consolidate the estimated $738 million Pfizer and Warner-Lambert media buying and planning ...
Pharma's Consolidation Creates New Kind of Player.(Statistical Data Included)
Companies become broader and more efficient. THE RECENT merger and acquisition activity in the drug industry is changing the landscape of pharmaceutical players. Within just the past two years, consolidation has created a new breed of super dr Companies...
Warner-Lambert's Shareholders Approve Merger With Pfizer
Business Editors
Pfizer eyes Carat for media prize;Merger with Warner-Lambert will create fourth-largest U.S. ad spender.(Brief Article)
When the merger of giants Pfizer and Warner-Lambert becomes official, the combined company will move up to become the No. 4 ad spender in the U.S. That has the industry abuzz over which media agency will be chosen to dole out those dollars. When...
Pfizer gets more (less?) than it bargained for
Warner-Lambert's withdrawal of Rezulin troglitazone from the market gives Pfizer something that is not part of the takeover negotiations - legal headaches. Upon completion of the $89 billion purchase, Pfizer will have the liability resulting from lawsuits claiming injury or death from use of Rezulin.
Pfizer ends the saga with Warner-Lambert.(Brief Article)
A three-month bitter battle entailing one of the most dramatic hostile takeover bids in the history of the pharmaceutical industry has ended with Pfizer acquiring Warner-Lambert for quoted estimates of between $84bn and $90bn. The new company will be A three-month bitter battle entailing one of...
Argentina: The local impact of the merge Pfizer - Werner Lambert.
The world merger of Pfizer and Warner Lambert will not represent a relevant change in its sales Argentina. Pfizer has annual sales for US$58mil in and ranks the 25th pharmaceuticals company, while Warner Lambert has not a direct presence, operating t The world merger of Pfizer...
Brazil: Warner-Lambert and Pfizer to generate sales of US$500mil.
The new drugs company resulting from the merger between Warner-Lambert and Pfizer will generate annual sales of US$500mil in Brazil.Warner-Lambert presently owns 5 plants in the country - 4 in Sao Paulo candies and 1 in Rio de Janeiro, where it con The new drugs company...
Taking the medicine.
After three months of pursuit, Warner-Lambert agreed to be taken over by Pfizer in a deal worth $90 billion, creating the world's largest drug company. Pfizer will also pay $1.8 billion to American Home Products for breaking up AHP's earlier agreed m After three months of...
Pfizer to buy Warner-Lambert in $92.3 billion transaction
NEW YORK AP -- After three bruising months of courtship, the world's two fastest-growing large drug companies, Pfizer will acquire Warner-Lambert in a $92.3 billion deal.
Since money 'talks', so does Warner-Lambert and Pfizer; agreement appears likely
Warner-Lambert board of directors, under pressure from stockholders, changed its strategy and authorized management to negotiate with Pfizer on its unsolicited takeover bid. Pfizer offered $75 billion for a merger just hours after Warner-Lambert announced a $55 billion agreement to merge with American Home Products.
Warner-Lambert Thwarts Pfizer.
FOLLOWING ITS board's authorization two weeks ago to negotiate merger discussions with Pfizer Inc., Warner-Lambert Company began talks with Procter & Gamble Company for a possible three-way' merger including American Home Products Corporation. FOLLOWING ITS board's authorization two weeks ago to negotiate ...
Warner-Lambert Pleased With Pfizer's Decision to Advise Not to Commence Its Consent Solicitation
Business Editors MORRIS PLAINS, N.J.--BUSINESS WIRE--December 23, 1999 Warner-Lambert announced today it was pleased that Pfizer has advised the Delaware Chancery Court that there is no need for the January 10, 2000 preliminary injunction hearing because it has decided not to commence its consent solicitation prior to the...
Warner-Lambert Announces Modified Delaware Court of Chancery Litigation Schedule
Business Editors, Legal Writers MORRIS PLAINS, N.J.--BUSINESS WIRE--Dec. 22, 1999 Warner-Lambert Company (NYSE: WLA) today announced that the Delaware Court of Chancery has modified the litigation schedule between Warner-Lambert, American Home Products and Pfizer, in light of Pfizer's filing of consent solicitation materials with the Securities and Exchange...
Warner-Lambert Advises Shareholders to Take No Action On Pfizer Consent Solicitation
MORRIS PLAINS, N.J.--BUSINESS WIRE--Dec. 16, 1999--
- Next »
- page 1 of 2
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
Industry Transcripts by Seeking Alpha
-
Salix Pharmaceuticals, Ltd. Q3 2008 Earnings Call Transcript
on Nov 21, 2008about SLXP
-
Emergent BioSolutions Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about EBS
-
Amicus Therapeutics, Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about FOLD
-
Heska Corporation Q3 2008 Earnings Call Transcript
on Nov 20, 2008about HSKA
-
Mannatech Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about MTEX
Pfizer Inc. Company Info
Contact Information
235 East 42nd Street
New York, NY
212 573-2323
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
